NO870027L - Ekspresjon av htlv-iii gag-gen. - Google Patents

Ekspresjon av htlv-iii gag-gen.

Info

Publication number: NO870027L
Authority: NO; Norway
Prior art keywords: polypeptide; gene; fragment; gag; htlv
Prior art date: 1986-01-06

Application number

NO870027A

Other languages

English (en)

Norwegian (no)

Other versions

NO870027D0 (no

Inventor

Richard Kramer

Premkumar Reddy

Michael Shaber

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-06

Filing date

1987-01-05

Publication date

1987-07-07

1987-01-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1987-01-05 Publication of NO870027D0 publication Critical patent/NO870027D0/no

1987-07-07 Publication of NO870027L publication Critical patent/NO870027L/no

Links

230000014509 gene expression Effects 0.000 title claims description 16
108090000623 proteins and genes Proteins 0.000 claims description 150
102000004169 proteins and genes Human genes 0.000 claims description 95
101710177291 Gag polyprotein Proteins 0.000 claims description 75
101710125418 Major capsid protein Proteins 0.000 claims description 72
208000030507 AIDS Diseases 0.000 claims description 58
239000012634 fragment Substances 0.000 claims description 56
210000004027 cell Anatomy 0.000 claims description 55
108090000765 processed proteins & peptides Proteins 0.000 claims description 46
102000004196 processed proteins & peptides Human genes 0.000 claims description 45
229920001184 polypeptide Polymers 0.000 claims description 41
108091028043 Nucleic acid sequence Proteins 0.000 claims description 34
238000000034 method Methods 0.000 claims description 29
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 27
230000002797 proteolythic effect Effects 0.000 claims description 26
239000013598 vector Substances 0.000 claims description 25
239000002243 precursor Substances 0.000 claims description 24
239000000427 antigen Substances 0.000 claims description 19
108091007433 antigens Proteins 0.000 claims description 19
102000036639 antigens Human genes 0.000 claims description 19
241000725303 Human immunodeficiency virus Species 0.000 claims description 18
125000003275 alpha amino acid group Chemical group 0.000 claims description 18
210000004369 blood Anatomy 0.000 claims description 15
239000008280 blood Substances 0.000 claims description 15
239000000203 mixture Substances 0.000 claims description 12
239000013604 expression vector Substances 0.000 claims description 11
210000005253 yeast cell Anatomy 0.000 claims description 11
150000001413 amino acids Chemical group 0.000 claims description 10
241000598436 Human T-cell lymphotropic virus Species 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 8
238000012360 testing method Methods 0.000 claims description 8
229960005486 vaccine Drugs 0.000 claims description 8
230000001900 immune effect Effects 0.000 claims description 7
230000035772 mutation Effects 0.000 claims description 7
230000008569 process Effects 0.000 claims description 5
238000006467 substitution reaction Methods 0.000 claims description 5
230000003612 virological effect Effects 0.000 claims description 5
238000012258 culturing Methods 0.000 claims description 3
230000001131 transforming effect Effects 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 2
230000001681 protective effect Effects 0.000 claims description 2
102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 claims 2
101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 claims 2
238000003259 recombinant expression Methods 0.000 claims 2
230000003053 immunization Effects 0.000 claims 1
238000002649 immunization Methods 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 88
239000013612 plasmid Substances 0.000 description 37
108700004026 gag Genes Proteins 0.000 description 28
108020004414 DNA Proteins 0.000 description 27
101150098622 gag gene Proteins 0.000 description 27
241000700605 Viruses Species 0.000 description 23
239000006166 lysate Substances 0.000 description 19
239000002609 medium Substances 0.000 description 14
239000000047 product Substances 0.000 description 14
235000001014 amino acid Nutrition 0.000 description 13
241000588724 Escherichia coli Species 0.000 description 12
108091005804 Peptidases Proteins 0.000 description 10
239000004365 Protease Substances 0.000 description 10
238000004458 analytical method Methods 0.000 description 10
229910019142 PO4 Inorganic materials 0.000 description 9
229940024606 amino acid Drugs 0.000 description 9
238000010367 cloning Methods 0.000 description 9
238000003119 immunoblot Methods 0.000 description 9
239000002773 nucleotide Substances 0.000 description 9
125000003729 nucleotide group Chemical group 0.000 description 9
230000017854 proteolysis Effects 0.000 description 9
102000053602 DNA Human genes 0.000 description 8
229960004452 methionine Drugs 0.000 description 8
244000005700 microbiome Species 0.000 description 8
108700004029 pol Genes Proteins 0.000 description 8
101150088264 pol gene Proteins 0.000 description 8
230000014616 translation Effects 0.000 description 8
241001430294 unidentified retrovirus Species 0.000 description 8
108091026890 Coding region Proteins 0.000 description 7
108020004705 Codon Proteins 0.000 description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 7
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 7
238000003780 insertion Methods 0.000 description 7
230000037431 insertion Effects 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
238000013519 translation Methods 0.000 description 7
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
108020004511 Recombinant DNA Proteins 0.000 description 6
238000003556 assay Methods 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
108020004999 messenger RNA Proteins 0.000 description 6
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
239000010452 phosphate Substances 0.000 description 6
238000000746 purification Methods 0.000 description 6
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
102000035195 Peptidases Human genes 0.000 description 5
239000011324 bead Substances 0.000 description 5
239000000872 buffer Substances 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
239000013613 expression plasmid Substances 0.000 description 5
239000000499 gel Substances 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000013599 cloning vector Substances 0.000 description 4
230000009089 cytolysis Effects 0.000 description 4
230000000120 cytopathologic effect Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000002405 diagnostic procedure Methods 0.000 description 4
239000003814 drug Substances 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
239000011521 glass Substances 0.000 description 4
238000002372 labelling Methods 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
239000000523 sample Substances 0.000 description 4
229920000936 Agarose Polymers 0.000 description 3
102000004594 DNA Polymerase I Human genes 0.000 description 3
108010017826 DNA Polymerase I Proteins 0.000 description 3
125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
241000276498 Pollachius virens Species 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
208000000389 T-cell leukemia Diseases 0.000 description 3
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
239000004098 Tetracycline Substances 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
108010067390 Viral Proteins Proteins 0.000 description 3
238000001042 affinity chromatography Methods 0.000 description 3
238000000376 autoradiography Methods 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
230000036039 immunity Effects 0.000 description 3
238000013198 immunometric assay Methods 0.000 description 3
238000001114 immunoprecipitation Methods 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
229930182817 methionine Natural products 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000008188 pellet Substances 0.000 description 3
150000002972 pentoses Chemical class 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000001566 pro-viral effect Effects 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
238000012216 screening Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
229960002180 tetracycline Drugs 0.000 description 3
229930101283 tetracycline Natural products 0.000 description 3
235000019364 tetracycline Nutrition 0.000 description 3
150000003522 tetracyclines Chemical class 0.000 description 3
238000001262 western blot Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
206010001513 AIDS related complex Diseases 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
101710132601 Capsid protein Proteins 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
-1 GALI Proteins 0.000 description 2
206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 2
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 2
125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
101000582398 Staphylococcus aureus Replication initiation protein Proteins 0.000 description 2
108020005038 Terminator Codon Proteins 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
230000027455 binding Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
230000037433 frameshift Effects 0.000 description 2
230000006870 function Effects 0.000 description 2
230000004927 fusion Effects 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000012010 growth Effects 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
230000000652 homosexual effect Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
230000003228 microsomal effect Effects 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000186046 Actinomyces Species 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
241000714195 Aids-associated retrovirus Species 0.000 description 1
108010032595 Antibody Binding Sites Proteins 0.000 description 1
241000271566 Aves Species 0.000 description 1
241001213911 Avian retroviruses Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
229930182818 D-methionine Natural products 0.000 description 1
FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
101710170658 Endogenous retrovirus group K member 10 Gag polyprotein Proteins 0.000 description 1
101710186314 Endogenous retrovirus group K member 21 Gag polyprotein Proteins 0.000 description 1
101710162093 Endogenous retrovirus group K member 24 Gag polyprotein Proteins 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
101710094596 Endogenous retrovirus group K member 8 Gag polyprotein Proteins 0.000 description 1
101710177443 Endogenous retrovirus group K member 9 Gag polyprotein Proteins 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
101150038242 GAL10 gene Proteins 0.000 description 1
102100024637 Galectin-10 Human genes 0.000 description 1
241000193385 Geobacillus stearothermophilus Species 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
208000008771 Lymphadenopathy Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
241000714177 Murine leukemia virus Species 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
101710142250 Protein p56 Proteins 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
101710167911 Repressible acid phosphatase Proteins 0.000 description 1
101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
206010042971 T-cell lymphoma Diseases 0.000 description 1
208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
101150102866 adc1 gene Proteins 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000011681 asexual reproduction Effects 0.000 description 1
238000013465 asexual reproduction Methods 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
230000008827 biological function Effects 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
238000009534 blood test Methods 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000012501 chromatography medium Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000002967 competitive immunoassay Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
108700004025 env Genes Proteins 0.000 description 1
101150030339 env gene Proteins 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000000284 extract Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
108010027225 gag-pol Fusion Proteins Proteins 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229960004198 guanidine Drugs 0.000 description 1
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
230000035876 healing Effects 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
238000005304 joining Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000004811 liquid chromatography Methods 0.000 description 1
208000018555 lymphatic system disease Diseases 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
108091005573 modified proteins Proteins 0.000 description 1
102000035118 modified proteins Human genes 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
101710085459 p48 protein Proteins 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
108010089520 pol Gene Products Proteins 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
230000004222 uncontrolled growth Effects 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1
108010082737 zymolyase Proteins 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

NO870027A 1986-01-06 1987-01-05 Ekspresjon av htlv-iii gag-gen. NO870027L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81664586A	1986-01-06	1986-01-06

Publications (2)

Publication Number	Publication Date
NO870027D0 NO870027D0 (no)	1987-01-05
NO870027L true NO870027L (no)	1987-07-07

Family

ID=25221244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO870027A NO870027L (no)	1986-01-06	1987-01-05	Ekspresjon av htlv-iii gag-gen.

Country Status (5)

Country	Link
EP (1)	EP0230222A1 (da)
JP (1)	JPS62164696A (da)
AU (1)	AU6713287A (da)
DK (1)	DK3687A (da)
NO (1)	NO870027L (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR860915B (en) *	1985-04-08	1986-07-11	Genetic Systems Corp	Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
FR2625100A2 (fr) *	1986-03-13	1989-06-30	Lurhuma Zirimwabagabo	Utilisation d'antigenes pour la preparation de vaccins, proteine rendue immunogene et composition pharmaceutique la comportant
US5075211A (en) *	1986-03-26	1991-12-24	Genetic Systems Corporation	Synthetic antigen for the detection of AIDS-related disease
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) *	1986-05-19	1991-01-08	Viral Technologies Inc.	HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
DK643188A (da) *	1987-11-24	1989-05-25	Smithkline Biolog	Ekspression af hiv-proteiner i e.coli og s.cerevisiae
JPH01148183A (ja) *	1987-12-04	1989-06-09	Hiroshi Shibuta	組み換えワクチニアウイルス
IL89993A0 (en) *	1988-04-25	1989-12-15	Phillips Petroleum Co	Expression of the hiv 24kda gag protein in methylotrophic yeasts
IL90048A0 (en) *	1988-04-25	1989-12-15	Merck & Co Inc	Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
AP129A (en) *	1988-06-03	1991-04-17	Smithkline Biologicals S A	Expression of retrovirus gag protein eukaryotic cells
FR2632310B1 (fr) *	1988-06-06	1992-04-10	Pasteur Institut	Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
GB2220939B (en) *	1988-06-10	1992-02-26	Medical Res Council	Peptide fragments of hiv and their use in vaccines and diagnosis
EP0352060A3 (en) *	1988-07-21	1990-12-27	Takeda Chemical Industries, Ltd.	Expression plasmid and use thereof
US5219725A (en)	1988-12-05	1993-06-15	Idexx Laboratories Incorporated	Monoclonal antibodies to feline-t-lymphotropic lentivirus
WO1990013573A1 (en) *	1989-05-08	1990-11-15	Idexx Corporation	Polypeptides of feline t-cell lymphotropic lentivirus
EP0398707A1 (en) *	1989-05-17	1990-11-22	Sangstat Medical Corporation	Treatment and diagnosis of human lymphotropic viruses
GB8918200D0 (en) *	1989-08-09	1989-09-20	Medical Res Council	The peptide fragments of hiv
IL95738A (en) *	1989-09-23	1996-11-14	Hoechst Ag	Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
NZ235538A (en) *	1989-10-12	1992-06-25	Viral Technologies Inc	Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
WO1991009869A1 (en) *	1990-01-05	1991-07-11	Medical Research Council	Hiv-1 core protein fragments
WO1991018990A1 (en) *	1990-05-28	1991-12-12	The Research Foundation For Microbial Diseases Of Osaka University	Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
DE69130396T2 (de) *	1990-08-16	1999-06-24	Genelabs Diagnostics Pte Ltd., Singapore	Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
PT700445E (pt)	1993-06-04	2002-07-31	Whitehead Biomedical Inst	Proteinas de stress e suas utilizacoes
EP0907740A1 (en) *	1997-01-02	1999-04-14	Universidade Federal De Minas Gerais	THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1)
AU9310298A (en) *	1997-09-09	1999-03-29	Trustees Of Columbia University In The City Of New York, The	T-independent conjugate-vaccines
US5972339A (en) *	1997-11-13	1999-10-26	The General Hospital Corporation	Method of eliciting anti-HIV-1 helper T cell responses
NO311807B1 (no)	1999-03-04	2002-01-28	Bionor Immuno As	HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
US6964851B2 (en)	1999-12-07	2005-11-15	Stressgen Biotechnologies Corp.	Compositions and methods for detecting stress-inducible proteins
EP1253939B1 (en)	2000-01-14	2009-08-05	Whitehead Institute For Biomedical Research	In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
HRP20021015A2 (en)	2000-06-26	2004-02-29	Stressgen Biotechnologies Corp	Human papilloma virus treatment
US20150174235A1 (en)	2012-06-06	2015-06-25	Bionor Immuno As	Vaccine
JP2017523166A (ja)	2014-07-11	2017-08-17	ビオノールイミュノエーエスＢｉｏｎｏｒＩｍｍｕｎｏＡｓ	ヒト免疫不全ウイルスｉ（ｈｉｖ）の病理学的影響を減少及び／若しくは遅延させるか又は後天性免疫不全症候群（ａｉｄｓ）を発症するリスクを低減させる方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341423C (en) *	1984-10-31	2003-03-04	Paul A. Luciw	Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
EP0187041B1 (en) *	1984-12-24	1996-05-15	Genentech, Inc.	Fusions of AIDS-related polypeptides

1987
- 1987-01-05 AU AU67132/87A patent/AU6713287A/en not_active Abandoned
- 1987-01-05 NO NO870027A patent/NO870027L/no unknown
- 1987-01-05 JP JP62000334A patent/JPS62164696A/ja active Pending
- 1987-01-05 EP EP87100064A patent/EP0230222A1/en not_active Withdrawn
- 1987-01-05 DK DK003687A patent/DK3687A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPS62164696A (ja)	1987-07-21
AU6713287A (en)	1987-07-09
DK3687D0 (da)	1987-01-05
DK3687A (da)	1987-07-07
EP0230222A1 (en)	1987-07-29
NO870027D0 (no)	1987-01-05

Publication	Publication Date	Title
NO870027L (no)	1987-07-07	Ekspresjon av htlv-iii gag-gen.
EP0199301B2 (en)	1997-07-09	Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein fragments and method of testing for AIDS
Yamashiro et al.	1991	Phosphorylation of non-muscle caldesmon by p34 cdc2 kinase during mitosis
US5677143A (en)	1997-10-14	Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
US5141867A (en)	1992-08-25	Nucleotide sequence encoding a human immunodeficiency virus antigen
US4861707A (en)	1989-08-29	Human immunodeficiency virus antigen
DK172274B1 (da)	1998-02-16	HTLV-III-virusprotein, DNA-sekvens, der koder herfor, fremgangsmåde til fremstilling heraf, fremgangsmåde til detektion af AIDS-virus samt antistoffer mod AIDS-virus
EP0258404B1 (en)	1992-05-20	Method of detecting antibody against htlv-iii
US5221610A (en)	1993-06-22	Diagnostic method and composition for early detection of HIV infection
US4784941A (en)	1988-11-15	Expression and diagnostic use of pENV-3 encoded peptides which are immunologically reactive with antibodies to LAV
EP0436634A1 (en)	1991-07-17	Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
JP2637278B2 (ja)	1997-08-06	Ｈｔｌｖ―▲ｉ▼の合成エンベロープペプチド
KR960005181B1 (ko)	1996-04-22	재조합 htlv-ⅲ 단백질 및 이의 용도
NZ225833A (en)	1990-12-21	Hiv proteins and peptides, immunoassay and vaccines
EP0453563A1 (en)	1991-10-30	Diagnostic proteins to test for more than one antibody
US5134227A (en)	1992-07-28	DNA encoding immunoreactive, chimeric HTLV-III GAG proteins
EP0345792A2 (en)	1989-12-13	HTLV-I / HIV-1 fusion proteins
US5773210A (en)	1998-06-30	Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
KR910000748B1 (ko)	1991-02-06	사람 면역결핍증 바이러스의 gag-암호화된 단백질
Marcus-Sekura et al.	1990	Expression of HIV-1 integrase in E. coli: immunological analysis of the recombinant protein
EP0980388A1 (en)	2000-02-23	Vif-derived hiv protease inhibitors
EP0235923B1 (en)	1991-01-09	Sor gene product from human t-cell lymphotropic virus iii
CA2017936A1 (en)	1990-12-01	Htlv-1 env gene products expressed in e. coli
Kreusel et al.	1993	Mouse monoclonal antibodies recognizing the activation domains of HIV-1 rev transactivator
WO1996012023A1 (en)	1996-04-25	A recombinant protein designated dev-1, useful in the detection of hiv, dna sequence encoding the protein, and immunoassays using the protein